Medication Development for Opioid and Alcohol Abuse

NCT03205423 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Opioid-use Disorder
Alcohol Use Disorder

Interventions

DRUG: Gabapentin

Sponsor

New York State Psychiatric Institute